Ariad Pharmaceuticals (ARIA +6.2%) trades higher after catching positive comments and a price...

|By:, SA News Editor

Ariad Pharmaceuticals (ARIA +6.2%) trades higher after catching positive comments and a price target increase from Rodman & Renshaw. In a report to clients, analysts note that the potential of the firm's ponatinib treatment remains untapped and other drugs in the pipeline should also be catalysts.